Оценка результатов хирургического лечения больных раком грудного отдела пищевода после индукционной терапии (стр. 23 )

119.  Pennathur A., Zhang J., Chen H., Luketich J. D The "best operation" for esophageal cancer? // Ann. rg. – 2010 – Vol.89(6) – S.2163-2167

120.  Peyre C. G., Hagen J. A., DeMeester S. R., Altorki N. K., et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection // rg. – 2008 – Vol.248(4) – p.549-556

121.  Pottgen C., Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer: a meta-analysis of the randomized trials // Cancer Treat Rev. – 2012 – Vol.38 – p.599-604

122.  Preston S. R., Clark G. W., Martin I. G., Ling H. M., Harris K. M. Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma // Br. rg. – 2003 – Vol.90 – p.1220–1224

123.  Puli S. R., Reddy J. B., Bechtold M. L., et al. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review // World J. Gastroenterol. – 2008 – Vol.1 – p.1479–1490

124.  Quint L. E., Bogot N. R. Staging esophageal cancer // Cancer Imaging – 2008 – A – S33–S42

125.  Raval M., Zouain N. The effectiveness of high dose rate brachytherapy using a special applicator set with external beam radiation treatment and chemotherapy followed by surgery as a treatment of adenocarcinoma of the esophagus: A case series of single institution with literature review // J. of Can. Research and Experimental Oncol. – 2011 – Vol.3 – p.1-7

126.  Reid T. D., Davies I. L., Mason J. et al. Stage for Stage Comparison of Recurrence Patterns after Definitive Chemoradiotherapy or Surgery for Oesophageal Carcinoma // Clin. Oncol. – 2012 – Vol.24 – p.617-624

127.  Rice T. W. Diagnosis and staging of esophageal cancer. In:Pearson FG, Patterson GA, eds. Pearson’s thoracic and esophageal surgery. 3rd edn. Philadelphia: Churchill Livingstone // Elsevier – 2008 – p.454–463

128.  Rice T. W., Zuccaro G. Jr., Adelstein D. J., et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status // Ann. rg. – 1998 – Vol.65(3) – p.787-792

129.  Rindani R., Martin C. J., Cox M. R. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? // Aust. NZ rg. – 1999 – Vol.69(3) – p.187-194

130.  Rizk N. P., Ishwaran H., Rice T. W., et al. Optimum lymphadenectomy for esophageal cancer // rg. – 2010 – Vol.251(1) – p.46-50

131.  Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study // Gastroenterology – 2005 – Vol.129 – p.1825–1831

132.  Rosenblatt E., Jones G., Sur R. K., et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency // Radiother. Oncol. – 2010 – Vol.97(3) – p.488-494

133.  Roussell A., Haegele P., Paillot B. Results of the EORTC-GTCCG phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer // Proc. Annu. Meet. Am. Soc. Clin. Oncol. – 1994 – Vol.13 – p.583

134.  Ruhstaller T, Widmer L, Schuller JC, et al. Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02) // Ann. Oncol. – 2009 – Vol.20 – №9 – p.1522-1528

135.  Sannohe Y., Hiratsuka R., Doi K. Limph Node metastasis in cancer of the thoracic Esophagus // Am. rg. – 1981 – Vol.141(2) – p.216-218

136.  Sepesi B., Watson T. J., Zhou D,. et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens // Journal of the American College of Surgeons – 2010 – Vol.210(4) – p.418-427

137.  Sharan K., Fernandes D. J., Saxena P. et al. Treatment outcomes after intraluminal brachytherapy following definitive chemoradiotherapy in patients with esophageal cancer // J. of Can. Research and Therapeutics. – 2014 – Vol.10 – p.337-341

138.  Sharma D., Thakur A., Toppo S. et al. Lymph node counts in indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach // Asian rg. – 2005 – Vol.28(2) – p.116-120

139.  Sharma R., Yang G. Y., Nava H. R. A single institution experience with neoadjuvant chemoradiation (CRT) with irinotecan (I) and cisplatin (C) in locally advanced esophageal carcinoma (LAEC) // J. Clin. Oncol. – 2009 – Vol.27. – p.15

140.  Shen W., Hu P., Cao J., et al. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: Meta-analysis of 15 studies // Journal of International Medical Research – 2014 – Vol.42(5) – p.1065–1076

141.  Shridhar R., Almhanna K., Meredith K. L. Radiation Therapy and Esophageal Cancer // Cancer Control – 2013 – Vol.20 – № 2 – p.97-110

142.  Siddiqui F. A., Atkins K. M., Diggs B. S. et al. Overall survival analysis of neoadjuvant chemoradiotherapy and esophagectomy for esophageal cancer // J. Gastrointest. Oncol. – 2014 – Vol.5 – p.86-91

143.  Singh R. et al. NBI for upper gastrointestinal tract lesions, Narrow band imaging with magnification for the diagnosis of lesions in the upper gastrointestinal tract // World J. Gastrointest. Endosc. – 2013 – Vol.5(12) – p.584-589

144.  Sjoquist K. M., Burmeister B. H., Smithers B. M. et rvival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis // Lancet Oncology – 2011 – Vol.12 – p.681-692

145.  Spigel D. R., Greco F. A., Meluch A. A., et al. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction // J. Clin. Oncol. – 2010 – Vol.28 – p.2213-2219

146.  Sumie H. et al. Usefulness of magnifying endoscopy with narrow-band imaging for diagnosis of depressed gastric lesions // Molecular and Clinical Oncology – 2014 – Vol.2 – p.129-133

147.  Sur R., Donde B., Falkson C., et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer // Brachytherapy – 2004 – Vol.3(4) – p.191-195

148.  Sur R. K., Levin C. V., Donde B., et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study // Int. J. Radiat. Oncol. Biol. Phys. – 2002 – Vol.53(1) – p.127-133

149.  Tahara M., Ohtsu A., Hironaka S. et al. Clinical Impact of Criteria for Complete Response (CR) of Primary Site to Treatment of Esophageal Cancer // Jpn. J. Clin. Oncol. – 2005 – Vol.35(6) – p.316–323

150.  Tangoku A., Yamamoto Y., Furukita Y., et al. The New Era of Staging as a Key for an Appropriate Treatment for Esophageal Cancer // Ann. Thorac. rg. – 2012 – Vol.18 – p.190–199

151.  Taylor M. D., LaPar D. J., Davis J. P., et al. Induction Chemoradiotherapy and Surgery for Esophageal Cancer: Survival Benefit With Downstaging // Ann. rg. – 2013 – Vol.96 – p.225–231

152.  Tepper J., Krasna M. J., Niedzwiecki D., et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 // J. Clin. Oncol. – 2008 – Vol.26 – p.1086-1092

153.  Thomas K., Varghese Jr. W.L., Hofstetter N. P., et al. The Society of Thoracic Surgeons Guidelines on the Diagnosis and Staging of Patients With Esophageal Cancer // Ann. rg. – 2013 – Vol.96 – p.346–356

154.  TNM: Классификация злокачественных опухолей / Под ред. и др; пер. с англ. и научн. ред. , . // М.: Логосфера – 2011 – 304 с.

155.  Urba S. G., Orringer M. B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma // J. Clin. Oncol. – 2001 – Vol.19(2) – p.305-313

156.  Urschel J. D., Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer // Am. rg. – 2003 – Vol.185 – p.538-543

157.  Urschel J. D., Vasan H., Blewett C. J. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer // Am. rg. – 2002 – Vol.183 – p.274-279

158.  van Hagen P., Hulshof M. C., van Lanschot J. J., et al. Preoperative chemoradiotherapy for esophageal or junctional cancer // N. Engl. J. Med. – 2012 – Vol.366 – p. 2074-2084

159.  van Vliet E. P., Heijenbrok-Kal M. H., Hunink M. G., et al. Staging investigations for oesophageal cancer: a meta-analysis // Br. J. Cancer – 2008 – Vol.98 – p.547-557

160.  van Westreenen H. L., Westerterp M., Bossuyt P. M., et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer // J. Clin. Oncol. – 2004 – Vol.22 – p.3805–3812

161.  Varghese T. K., Hofstetter Jr. W.L., Rizk N. P., et al. The Society of Thoracic Surgeons Guidelines on the Diagnosis and Staging of Patients With Esophageal Cancer // Ann. rg. – 2013 – Vol.96 – p.346–356

162.  Vazquez-Sequeiros E., Wiersema M. J., Clain J. E., et al. Impact of lymph node staging on therapy of esophageal carcinoma // Gastroenterology – 2003 – Vol.125(6) – p.1626-1635

163.  Vuong T., Szego P., David M. et al. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy // Int. J. Radiation Oncology Biol. Phys. – 2005 – Vol.63 – №3 – p.758–764